Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E14.67 EPS (ttm)2.46 Insider Own0.04% Shs Outstand5.55B Perf Week-1.58%
Market Cap201.36B Forward P/E10.75 EPS next Y3.35 Insider Trans-7.21% Shs Float5.55B Perf Month-5.26%
Income13.85B PEG2.73 EPS next Q0.72 Inst Own72.00% Short Float0.81% Perf Quarter12.52%
Sales49.20B P/S4.09 EPS this Y62.30% Inst Trans-1.45% Short Ratio1.64 Perf Half Y16.67%
Book/sh11.58 P/B3.11 EPS next Y14.47% ROA8.30% Target Price41.79 Perf Year0.75%
Cash/sh2.04 P/C17.69 EPS next 5Y5.37% ROE22.00% 52W Range27.88 - 40.97 Perf YTD-7.99%
Dividend1.52 P/FCF44.01 EPS past 5Y14.70% ROI14.70% 52W High-12.01% Beta0.66
Dividend %4.22% Quick Ratio1.20 Sales past 5Y0.90% Gross Margin80.40% 52W Low29.30% ATR0.69
Employees88300 Current Ratio1.40 Sales Q/Q-11.00% Oper. Margin31.10% RSI (14)38.56 Volatility1.82% 2.01%
OptionableYes Debt/Eq0.99 EPS Q/Q-31.50% Profit Margin28.80% Rel Volume0.49 Prev Close35.76
ShortableYes LT Debt/Eq0.79 EarningsJul 28 BMO Payout57.90% Avg Volume27.55M Price36.05
Recom2.50 SMA20-1.56% SMA50-3.90% SMA200-1.05% Volume13,609,057 Change0.81%
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
Sep-26-20 06:16AM  
Sep-25-20 08:37PM  
04:25PM  
02:44PM  
11:49AM  
10:39AM  
09:07AM  
Sep-24-20 10:23PM  
06:45PM  
04:25PM  
04:14PM  
03:09PM  
03:07PM  
12:14PM  
11:33AM  
06:09AM  
Sep-23-20 04:25PM  
04:20PM  
04:07PM  
02:13PM  
01:28PM  
11:06AM  
10:52AM  
10:51AM  
10:37AM  
08:52AM  
08:07AM  
06:45AM  
06:12AM  
05:48AM  
Sep-22-20 05:19PM  
04:25PM  
04:25PM  
12:19PM  
10:01AM  
10:00AM  
08:35AM  
06:09AM  
Sep-21-20 05:45PM  
04:31PM  
04:25PM  
03:33PM  
10:42AM  
10:35AM  
08:00AM  
05:35AM  
02:27AM  
Sep-20-20 08:23AM  
06:09AM  
Sep-18-20 07:13PM  
06:05PM  
04:44PM  
04:25PM  
03:57PM  
03:12PM  
02:36PM  
01:58PM  
11:12AM  
10:20AM  
09:51AM  
09:26AM  
09:26AM  
06:10AM  
06:08AM  
05:46AM  
Sep-17-20 10:08PM  
05:48PM  
05:23PM  
05:02PM  
04:54PM  
04:25PM  
04:20PM  
04:16PM  
03:29PM  
11:06AM  
11:00AM  
08:08AM  
07:22AM  
07:00AM  
06:05AM  
Sep-16-20 04:43PM  
04:25PM  
03:54PM  
02:04PM  
01:57PM  
12:57PM  
10:29AM  
08:33AM  
08:00AM  
06:36AM  
03:05AM  
01:12AM  
Sep-15-20 10:33PM  
04:27PM  
04:16PM  
03:49PM  
01:56PM  
01:31PM  
11:10AM  
10:52AM  
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, such as cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; oncology, such as biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; licensing agreement with Akcea Therapeutics, Inc; strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; material transfer and collaboration agreement with BioNTech SE to co-develop COVID-19 vaccine; clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; and research collaboration and license agreement with BioInvent International AB. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BLAYLOCK RONALD EDirectorAug 06Buy38.5513,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM
DAMICO JENNIFER B.SVP & ControllerApr 29Sale38.352,18183,6419,647May 01 03:56 PM
JOHNSON RADY AExecutive Vice PresidentApr 29Sale38.3613,125503,47563,940May 01 03:56 PM
ROGERS DAWNExecutive Vice PresidentApr 29Sale38.1313,000495,6904,823May 01 03:56 PM
LANKLER DOUGLAS MExecutive Vice PresidentApr 29Sale37.8565,0002,460,37278,276May 01 03:56 PM
PFIZER INC10% OwnerMar 16Buy16.00312,5005,000,0001,481,719Mar 16 07:15 PM
GOETTLER MICHAELGroup PresidentFeb 28Option Exercise27.3722,852625,45953,036Mar 03 12:54 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3715,996437,81187,956Mar 03 12:54 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3738,8481,063,270172,542Mar 03 12:54 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 28Option Exercise27.3737,9341,038,254140,256Mar 03 12:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 28Option Exercise27.3717,824487,84330,045Mar 03 12:54 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.3791,4082,501,837222,496Mar 03 12:55 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37100,5482,751,999504,427Mar 03 12:55 PM
BOURLA ALBERTChairman & CEOFeb 28Option Exercise27.3733,135906,905232,888Mar 03 12:49 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3727,422750,540140,744Mar 03 12:49 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37173,6754,753,485556,084Mar 03 12:49 PM
YOUNG JOHN DGroup PresidentFeb 26Option Exercise34.59144,9285,013,060503,738Feb 28 07:32 PM
ROGERS DAWNExecutive Vice PresidentFeb 26Option Exercise34.5915,097522,20524,995Feb 28 07:28 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise34.5972,4642,506,530180,558Feb 28 07:28 PM
JOHNSON RADY AExecutive Vice PresidentFeb 26Option Exercise34.5933,4141,155,79093,211Feb 28 07:24 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise34.5988,5673,063,533189,936Feb 28 07:25 PM
GOETTLER MICHAELGroup PresidentFeb 26Option Exercise34.5920,129696,26245,557Feb 28 07:22 PM
Hwang AngelaGroup PresidentFeb 26Option Exercise34.5914,493501,31332,470Feb 28 07:22 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise34.59144,9285,013,060482,320Feb 28 07:19 PM
BOURLA ALBERTChairman & CEOFeb 26Option Exercise34.5988,5673,063,533274,479Feb 28 07:16 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 26Option Exercise34.5924,155835,521131,196Feb 28 07:15 PM
Gottlieb ScottDirectorJan 30Buy37.001,00036,9974,000Jan 31 08:06 AM